HOME > NATION > Article

Text Size

small

medium

large


World's 1st iPS Therapy for Spinal Cord Injuries Starts in Japan

World's 1st iPS Therapy for Spinal Cord Injuries Starts in Japan

   Tokyo, Jan. 14 (Jiji Press)--Japan's Keio University said Friday it has started a clinical research to transplant neural progenitor cells derived from induced pluripotent stem, or iPS, cells into patients with spinal cord injuries, the first such attempt in the world.
   A patient who received the transplant in December last year has developed no abnormalities, and the surgery was a success, according to the university.
   At the same time, the university said it is still not possible to determine whether the patient's motor functions have actually recovered.
   Keio University professor Hideyuki Okano and his team have received iPS cells derived from a healthy person from Kyoto University and converted them into cells that are capable of developing into nerves.
   About 2 million of such cells were injected into the damaged section of the patient's spinal cord. The team will verify the safety and efficacy of the treatment while having the patient go through rehabilitation over a year.

To read a full story, please click here to find out how to subscribe.

NATION

Aomori Tourism Information

HEADLINES

POLITICS
Chief Cabinet Secretary Matsuno Vows Max Effort to Bring Back Japanese Abductees
ECONOMY
Tokyo Forex (5 P.M.): U.S. Dollar=113.79-80 Yen; Euro=1.1465-1466 Dollars
SPORTS
Pro Baseball: Shingo Takatsu, Masashi Yamamoto Inducted into Hall of Fame
OTHER
Japan Daily Coronavirus Count Tops 20,000 for 1st Time in over 4 Months

AFP-JIJI PRESS NEWS JOURNAL


Photos